Please wait...

Learn

Finding accredited CPD

Shortages of benzathine benzylpenicillin G in Australia highlight the need for new sovereign manufacturing capability

Description

Benzathine benzylpenicillin G (BPG) is the most effective treatment for syphilis and prevention of rheumatic heart disease (RHD), both of which disproportionately affect Aboriginal and Torres Strait Islander people. The ongoing syphilis epidemic in Australia highlights the importance of a reliable supply of high quality BPG in achieving Australia's commitments to ending RHD and preventing new cases of congenital syphilis.

This MJA Perspective shares more.


Details

Authors: Rosemary Wyber, Glenn Pearson and Laurens Manning

Article Type: Perspective

Provided by


CPD Activity Details
Topic
Pharmaceutical Preparations, Cardiovascular Diseases, Indigenous Health
CAPE Aspects
_
Effective Year

Educational Activities (EA) - 0.30

Reviewing Performance (RP) - 0.0

Measuring Outcomes (MO) - 0.0

You have to log in to see the content of this module.

*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)